1How Exactly Steroids Cause AVN — The Biology
AVN (avascular necrosis) is bone death caused by interrupted blood supply to the femoral head (the ball of the hip joint). Steroids cause this through three distinct mechanisms, each of which is now well-established in the medical literature.
Mechanism 1 — Fat cell enlargement (lipocyte hypertrophy): corticosteroids cause fat cells within the bone marrow to enlarge and multiply. In the enclosed space of the femoral head, this enlargement increases intraosseous pressure — essentially compressing the tiny blood vessels that supply the bone from within. Chronically elevated intraosseous pressure compromises microcirculation and leads to ischaemia (blood starvation) of the bone tissue.
Mechanism 2 — Fat emboli in bone vessels: steroids cause elevated blood lipid levels and may promote the formation of fat emboli — small fat particles that can lodge in the small arterial vessels supplying the femoral head, blocking blood flow. This is a more acute mechanism and may explain why AVN can develop even after relatively short courses of high-dose steroids.
Mechanism 3 — Impaired bone repair: corticosteroids suppress osteoblast activity (the cells that build and repair bone) while increasing osteoclast activity (cells that break down bone). This imbalance means that even if the initial ischaemic injury is not catastrophic, the bone cannot repair the micro-damage that accumulates — and progressive collapse follows.
Why the femoral head is specifically vulnerable: the femoral head has a particularly precarious blood supply — most of it comes through a single arterial system that wraps around the femoral neck. There is very little collateral circulation. When any mechanism compromises blood flow here, there is no backup supply.
2COVID Treatment Protocols and AVN Risk — What Doses Were Used
The COVID treatment protocols that were widely used in India — particularly during the second wave in 2021 — involved steroid doses that are well above the threshold associated with AVN risk in the medical literature.
The primary steroids used in COVID treatment:
Dexamethasone 6mg daily for 10 days: the RECOVERY trial protocol, which became the global standard. This dose, while relatively modest, was often exceeded in practice — particularly in ICU settings and in private hospitals where more aggressive protocols were used.
Methylprednisolone 500mg-1g IV (pulse therapy): used in severe COVID with cytokine storm, ARDS, or rapidly worsening oxygen saturation. This is high-dose IV pulse therapy — a dose range that is directly associated with the highest AVN risk in non-COVID literature (used in lupus, organ transplant, and severe asthma management, all of which have documented AVN as a complication).
Prednisolone 40-60mg oral for 5-14 days: widely prescribed in moderate COVID, often without the monitoring or follow-up that would be standard in other high-dose steroid situations.
What the pre-COVID literature already showed: AVN has been documented after steroid use in other contexts for decades. In patients with SLE (lupus) receiving high-dose steroids, AVN rates of 5-30% are reported. In organ transplant recipients on long-term steroids, AVN rates of 3-11% are documented. The COVID situation exposed a much larger population — millions rather than thousands — to similar or higher steroid doses, often with less monitoring.
Important nuance: not everyone who received COVID steroids will develop AVN. Risk depends on the total dose, duration, individual susceptibility (some genetic factors have been identified), concurrent factors (alcohol use, smoking, pre-existing vascular disease), and possibly the timing of steroid use in the disease course.
3The Timeline — When Does Post-COVID AVN Appear
This is the most clinically critical information for COVID survivors who received steroids.
Typical onset: AVN from steroid exposure typically becomes symptomatic 6-24 months after the steroid course. This is not a rigid window — cases have been reported at 3 months and at 3 years — but the 6-24 month period is when the majority of cases present clinically.
Why the delay: steroids cause the initial vascular insult acutely, but the bone necrosis itself progresses over months. Grade 1 AVN (the earliest MRI-detectable stage) may be present at 3-6 months but may be asymptomatic. As the necrotic segment enlarges and approaches the subchondral bone, pain begins. In many patients, the first significant hip pain that brings them to a doctor corresponds to Grade 2 or even Grade 3 AVN on MRI — meaning the disease was silently progressing for months before the pain started.
The 2021-2022 cohort: the second COVID wave in India peaked in April-May 2021. Applying the 6-24 month window, this cohort would have started presenting with AVN symptoms from late 2021 through mid-2023. These patients are now 3-5 years post-steroid exposure and represent the most advanced cases — some with Grade 3-4 AVN who delayed evaluation because they attributed the pain to "post-COVID weakness."
The 2023-2025 population: patients who received COVID-related steroids during this period may now be entering the symptomatic window. Hip pain appearing now, 1-2 years after a COVID hospitalization with steroids, should be evaluated for AVN.
What is often missed: patients often attribute post-COVID hip pain to weakness, deconditioning, vitamin D deficiency, or general fatigue — all of which are common after COVID and explain the delay in diagnosis. The key differentiator is the location of pain (groin or anterior hip, not lower back) and its behaviour (worse with weight bearing, often better at complete rest).
4Who Is Most at Risk Among COVID Steroid Recipients
Not all COVID steroid recipients carry the same AVN risk. The following factors increase risk based on current evidence.
Higher risk:
Lower risk (but not zero):
Who should be screened proactively: any COVID survivor who received IV methylprednisolone or high-dose steroids for more than 7 days, especially if they have concurrent risk factors and new hip or groin pain — should have an MRI of both hips (bilateral screening is important because AVN is bilateral in 50-80% of cases).
5Symptoms and Diagnosis — When to Suspect AVN After COVID
The clinical presentation of post-COVID steroid-induced AVN is identical to other forms of AVN, but the context is different — which often causes diagnostic delay.
Symptoms to watch for:
The common misdiagnosis: post-COVID fatigue, vitamin D deficiency, or muscle weakness. These are real and common, but they do not cause the specific pattern of groin pain worsening with weight bearing. If pain has this location and character — the clinical diagnosis of exclusion should be AVN until proven otherwise.
How to get a definitive diagnosis:
X-ray first: in early AVN (Grade 1-2), X-ray is normal. A normal X-ray does NOT rule out AVN. This is the most critical point that causes diagnostic delay — patients get an X-ray, it comes back normal, and the doctor tells them it's just muscle strain.
MRI: the definitive investigation for early AVN. Grade 1-2 AVN is clearly visible on MRI with bone marrow oedema and abnormal signal in the femoral head — long before any X-ray changes. If you have post-COVID hip pain and a normal X-ray, an MRI is the appropriate next investigation.
Both hips should be imaged: even if only one hip hurts, bilateral MRI is recommended in steroid-induced AVN because the other hip may have silent AVN at an earlier stage.
6What to Do If You Think You Have Post-COVID AVN
This is actionable guidance — not to replace medical evaluation, but to navigate the system effectively.
Step 1 — Get an MRI, not just an X-ray: if you had COVID with high-dose steroids and now have hip/groin pain, you specifically need an MRI of both hips. State explicitly to your doctor: "I received high-dose steroids during COVID treatment. I have read that this is associated with AVN. I would like an MRI of both hips." A doctor who dismisses this request without a clear clinical reason should be asked again or a second opinion sought.
Step 2 — Understand your MRI report: the report will use ARCO staging or Ficat staging. Grade 1-2 on MRI means the femoral head has not collapsed — treatment options are widest here. Grade 3 means subchondral fracture. Grade 4 means collapse. The guide on AVN MRI grades on this site explains each stage in detail.
Step 3 — Stop all further steroid use if possible: if you are on any ongoing steroid treatment (for any reason), this should be reviewed with your treating doctor. Further steroid use in a patient who already has early AVN significantly accelerates progression.
Step 4 — Strict weight protection: until your grade is determined and a management plan is in place, avoid prolonged standing, running, heavy lifting, and uneven surfaces. This is not permanent — it is protective during the diagnostic workup.
Step 5 — See an orthopaedic surgeon AND consider additional evaluation: for Grade 1-2 AVN, an orthopaedic surgeon who manages AVN conservatively is important. For Grade 3, a second opinion is strongly advised — because the management of Grade 3 is genuinely contested. For Grade 4, hip replacement planning is the appropriate discussion.
The most important message: early diagnosis transforms the prognosis. Grade 1-2 AVN treated early has a meaningful chance of stabilisation and non-surgical management. The same disease found at Grade 4 has essentially no reversibility. The delay between COVID steroid exposure and symptom onset is the reason many patients present late — being aware of this timeline and acting when symptoms first appear is the single most important thing a COVID steroid recipient can do.